Physician Specializing in Rare Diseases Sought by State Agency

March 28, 2024

The Minnesota Rare Disease Advisory Council (RDAC) is looking for a physician licensed and practicing in the state with experience researching, diagnosing, or treating rare diseases. The three-year term begins in January 2025. 

RDAC is an executive branch state agency whose purpose is to improve care for the one in 10 Minnesotans living with a rare disease. RDAC is charged with the following:  

  • provide advice on policies, access, equity, research, diagnosis, treatment, and education related to rare diseases.  

  • provide resources, identifying and recommending best practices, identifying and addressing barriers faced by rare disease patients. 

  • advise agencies of state government on policies related to rare diseases. 

RDAC holds hybrid bimonthly meetings in January, March, May, July, September and November. In addition, all members are encouraged to serve on at least one working group/committee, which meets monthly.  

Interested candidates can apply on the Secretary of State, Boards and Commissions Website: Open Positions Search (state.mn.us) 

For more information, visit the RDAC website and/or contact the Executive Director Erica Barnes at erica.barnes@state.mn.us. 

Latest News

State Budget Forecast Shows Short-Term Surplus, Long-Term Deficit

December 4, 2025

On December 4, Minnesota Management and Budget (MMB) released its budget forecast for the 2026-27 biennium, showing a short-term budget surplus of $2.5 billion for the current biennium, but warned of a long-term $2.96 billion deficit for the 2028-29 biennium. 

Vaccine Integrity Project Urges Continuing HBV Vaccinations for Newborns

December 4, 2025

On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.  

Public Comment Period Regarding Insurance Mandates Open Through December 11

December 4, 2025

The Minnesota Department of Commerce (DOC) is now accepting public comments regarding proposed legislation to mandate insurance coverage of certain treatments.